SCHOTT Pharma AG & Co. KgaA engages in the provision of designing drug containment and drug delivery solutions. The company is headquartered in Mainz, Hessen and currently employs 4,689 full-time employees. The company went IPO on 2023-09-28. The firm is primarily engaged in designing advanced drug containment solutions and drug delivery systems for the pharmaceutical and biotech industries. The Company’s portfolio ranges from syringes and cartridges to vials and ampoules, all made using Type I Borosilicate Glass and high-grade pharmaceutical polymer.
Follow-Up Questions
STTPF hissesinin fiyat performansı nasıl?
STTPF 'in mevcut fiyatı $0 'dir, son işlem günde 0% decreased etti.
SCHOTT Pharma AG & Co KgaA için ana iş temaları veya sektörler nelerdir?
SCHOTT Pharma AG & Co KgaA Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
SCHOTT Pharma AG & Co KgaA 'in piyasa değerlemesi nedir?
SCHOTT Pharma AG & Co KgaA 'in mevcut piyasa değerlemesi $0 'dir
SCHOTT Pharma AG & Co KgaA al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 15 analist SCHOTT Pharma AG & Co KgaA için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 10 al, 3 tut, 2 sat ve 4 güçlü sat içermektedir
